| PEMOE45 | Building infection prevention and control capacity across PEPFAR programs in response to the COVID-19 pandemic | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PEMOE46 | A pandemic over an epidemic: surveying LGBTQI+ situation during COVID-19 pandemic in Thailand | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| PEMOE47 | Analyzing FY 19-21 PEPFAR PrEP uptake focusing on adolescent girls and young women and key populations | Poster exhibition | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPB045 | An estimate of the global burden of HIV-associated cryptococcal infection in adults in 2020 | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB046 | Hematological toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB047 | Voriconazole or amphotericin B deoxycholate: which is the preferred induction therapy in HIV-infected patients with talaromycosis? | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB048 | Immunogenicity and safety of yellow fever vaccination in people living with HIV | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB049 | Epidemiology of pneumonia in a multicenter cohort of people living with HIV | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPB050 | Prevalence and determinants of asymptomatic Leishmania infection in HIV-positive people and progression to symptomatic visceral leishmaniasis in Bihar, India | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |
| EPLBB02 | Chronic/latent viral infection prevalence and estimated all-cause mortality risk among women living with HIV and HIV-negative women participating in the British Columbia CARMA-CHIWOS Collaboration (BCC3) study: preliminary findings | E-poster | Opportunistic infections (excluding TB): Bacterial, non-TB mycobacterial, viral and parasitic infections |